Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axon Enterprise’s mission to build a connected public-safety operating system spans everything from TASER devices to cloud SaaS, and that breadth shows up in dense SEC documents. If you’ve ever tried to track how Software & Sensors subscription revenue moves against TASER hardware margins or wanted clarity on potential product-liability litigation, the 250-page annual report can feel overwhelming.
Stock Titan turns those pages into plain English. Our AI-powered summaries highlight what matters in every Axon annual report 10-K simplified, flagging segment revenue swings, deferred subscription backlog, and regulatory risk factors. Need the latest Axon quarterly earnings report 10-Q filing? We post it the moment it hits EDGAR and layer on instant earnings report filing analysis, so you see gross-margin trends before the call even starts. Real-time alerts surface Axon insider trading Form 4 transactions, letting you monitor executive stock transactions Form 4 without refreshing EDGAR. Material contract wins or product recalls appear in an Axon 8-K material events explained card, and the proxy statement executive compensation section is broken down so you can compare pay to performance.
Whether you’re screening for Axon Form 4 insider transactions real-time, trying to understand Axon SEC documents with AI, or simply searching for “Axon SEC filings explained simply,” this page keeps every filing type—10-K, 10-Q, 8-K, 4, S-8, 13G—in one place. You’ll find:
- AI-generated key takeaways and risk flags
- Downloadable original documents and redlined updates
- Searchable table to filter by filing type or date
Save hours and make decisions faster with complete, continuously updated coverage of Axon’s regulatory disclosures, all distilled into insights you can act on.
On June 30, 2025, Indivior PLC (Nasdaq/LSE: INDV) filed a Form 8-K to furnish information under Item 7.01 (Regulation FD). The company reported, via an attached press release (Exhibit 99.1), that its ordinary shares have been selected for inclusion in both the U.S. Russell 2000 and Russell 3000 indexes. The filing contains no financial statements, earnings figures, or operational updates; it strictly communicates the index-membership development. While purely informational, index inclusion typically broadens a company’s investor base and can enhance share liquidity because passive funds that track the Russell family of indexes are required to purchase constituent stocks. No additional material events, transactions, or strategic changes are disclosed in this report.
Axon Enterprise, Inc. (AXON) – Form 4 insider transaction summary: President Joshua Isner reported two transactions involving AXON common stock. On 16-Jun-2025, 680 shares were disposed under transaction code F (shares withheld to cover income-tax obligations triggered by restricted stock unit (RSU) vesting) at a price of $780.63 per share. On 17-Jun-2025, Isner sold 905 shares in the open market at $776.39 per share under a pre-arranged Rule 10b5-1 trading plan adopted on 21-Aug-2024.
Following these actions, Isner’s direct beneficial ownership declined from 270,320 shares to 268,735 shares, a reduction of roughly 0.6 % of his total position and an immaterial fraction of Axon’s ~74 million shares outstanding. No derivative securities were involved and no new options were granted or exercised. The filing indicates routine tax withholding and modest portfolio diversification rather than a strategic divestiture. Because the sales were both limited in size and executed under a 10b5-1 plan, the market impact is expected to be neutral to modestly negative.